1. Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL. Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet. 2013; 162:698–710. DOI:
10.1002/ajmg.b.32159.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, allcause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016; 388(10053):1459–1544. DOI:
10.1016/S0140-6736(16)31012-1.
6. Park SA, Sung KM. Development of a measurement of stress for hospitalized schizophrenic patient. J Korean Acad Nurs. 2014; 44(3):339–349. DOI:
10.4040/jkan.2014.44.3.339.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance strategy. JAMA Psychiatry. 2013; 70:913–920. DOI:
10.1001/jamapsychiatry.2013.19.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Hsiao CY, Hsieh MH, Tseng CJ, Chien SH, Chan CC. Quality of life of individuals with schizophrenia living in the community: relationship to socio-demographic, clinical and psychosocial characteristics. J Clin Nurs. 2012; 21(15-16):2367–2376. DOI:
10.1111/j.1365-2702.2012.04067.x.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Yoo SY. Developing a prediction model for quality of life in patients with schizophrenia. J Korean Acad Psychiatr Ment Health Nurs. 2014; 23(3):144–155. DOI:
10.12934/jkpmhn.2014.23.3.144.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning? Int J Ment Health Syst. 2010; 4(31):1–8. DOI:
10.1186/1752-4458-4-31.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Brissos S, Dias VV, Balanzá-Martinez V, Carita AI, Figueira ML. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res. 2011; 129(2-3):133–136. DOI:
10.1016/j.schres.2011.04.001.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Górna K, Jaracz K, Jaracz J, Kiejda J, Grabowska-Fudala B, Rybakowski J. Social functioning and quality of life in schizophrenia patients-relationship with symptomatic remission and duration of illness. Psychiatr Pol. 2014; 48(2):277–288.
14. Priebe S, McCabe R, Junghan U, Kallert T, Ruggeri M, Slade M, et al. Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011; 133(1-3):17–21. DOI:
10.1016/j.schres.2011.09.021.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Madhivanan S, Jayaraman K, Daniel SJ, Ramasamy J. Symptomatic remission in schizophrenia and its relationship with functional outcome measures in Indian population. J Clin Diagn Res. 2017; 11(1):VC05–VC07. DOI:
10.7860/JCDR/2017/22320.9242.
16. Meesters PD, Comijs HC, de Haan L, Smit JH, Eikelenboom P, Beekman AT, et al. Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients. Schizophr Res. 2013; 147(2-3):275–280. DOI:
10.1016/j.schres.2013.04.030.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Pitkänen A, Välimäki M, Kuosmanen L, Katajisto J, Koivunen M, Hätönen H, et al. Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomized clinical trial. Qual Life Res. 2012; 21(2):247–256. DOI:
10.1007/s11136-011-9944-1.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Loh SY, Abdullah A, Abu Bakar AK, Thambu M, Nik Jaafar NR. Structured walking and chronic institutionalized schizophrenia inmates: a pilot RCT study on quality of life. Glob J Health Sci. 2015; 8(1):238–248. DOI:
10.5539/gjhs.v8n1p238.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Wang FZ, Luo D, Kan W, Wang Y. Combined intervention with education and progressive muscle relaxation on quality of life, functional disability, and positive symptoms in patients with acute schizophrenia. J Altern Complement Med. 2015; 21(3):159–165. DOI:
10.1089/acm.2014.0128.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Schlosser D, Campellone T, Kim D, Truong B, Vergani S, Ward C, et al. Feasibility of PRIME: a cognitive neuroscience-informed mobile app intervention to enhance motivated behavior and improve quality of life in recent onset schizophrenia. JMIR Res Protoc. 2016; 5(2):e77. DOI:
10.2196/resprot.5450.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Kang BI. The effect of group art therapy on emotional expression, emotional behavior, interpersonal relationship, and quality of life in inpatients with schizophrenia. Clin Arts Ther Stud. 2015; 4(1):27–51.
22. Lambert M, Bock T, Schöttle D, Golks D, Meister K, Rietschel L, et al. Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with firstand multiple-episode schizophrenia spectrum disorders treated with Quetiapine immediate release (ACCESS Trial). J Clin Psychiatry. 2010; 71(10):1313–1323. DOI:
10.4088/JCP.09m05113yel.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Jeon GS, Gang M, Oh K. The effectiveness of the Nanta-program on psychiatric symptoms, interpersonal relationships, and quality of life in forensic inpatients with schizophrenia. Arch Psychiatr Nurs. 2017; 31(1):93–98. DOI:
10.1016/j.apnu.2016.09.005.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Ryu JM. The effects of group art therapy on the interpersonal relationship and the quality of life of chronic schizophrenic patients dwelling in the facilities. J Humanit Soc Sci 21. 2015; 6(4):213–231.
25. Choi HM. Effect of the group art therapy on stress coping strategy and quality of life in schizophrenia patients. Clin Arts Ther Stud. 2015; 4(1):131–150.
26. Kim KH, Kim TW. A case study of art therapy on the quality of life for chronic schizophrenic patient. Korean J Art Ther. 2017; 24(6):1531–1555.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Scottish Intercollegiate Guidelines Network (SIGN). Methodology check list 2: randomized controlled trials. SIGN [Internet]. 2013. cited 2013 May 9. Available from:
http://www.sign.ac.uk/our-guidelines.html.
29. Enhancing the QUAlity and Transparency Of health Research (EQUATOR). Reporting guidelines for main study types. EQUATOR [Internet]. 2013. cited 2013 Sep 2. Available from:
http://www.care-statement.org/downloads.
30. Marshall M, Lockwood A. WITHDRAWN: Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev. 2011; 13(4):CD001089. DOI:
10.1002/14651858.CD001089.pub2.